Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
crispr
3
×
life sciences
national blog main
biotech
deals
gene editing
national top stories
san francisco blog main
abbvie
allergan
alzheimer's disease
clinical trials
cynthia collins
cystic fibrosis
cystic fibrosis foundation
david walt
diagnostics
drugs
editas medicine
fda
feng zhang
gilead sciences
hepatitis c
illumina
incivek
jeff leiden
jennifer doudna
jim collins
kayldeco
leber congenital amaurosis type 10
mammoth biosciences
matt emmens
messenger rna therapeutics
michelle robertson
orkambi
parkinson's disease
paul matteis
What
medicines
3
×
editing
gene
abbvie
alliance
bio
biotech
cf
create
crisis
crispr
cystic
developer
diagnostic
diseases
editas
exits
experimental
fibrosis
fix
force
genetic
heats
helped
high
human
jeff
launches
leiden
pact
partnership
pharmaceuticals
profitable
pruning
race
research
returning
rights
roles
shaped
Language
unknown
unset
Current search:
crispr
×
medicines
×
boston
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M